Search results for "Infectious Diseases"
Latest COVID-19 guidelines come out against bamlanivimab, remdesivir
The NIH and the Infectious Diseases Society of America found insufficient data to support bamlanivimab, while the World Health Organization said the same about remdesivir. The FDA issued more emergency use authorizations, and research looked at racial and other disparities in COVID-19 outcomes.
https://immattersacp.org/weekly/archives/2020/11/24/1.htm
24 Nov 2020
Prepare for next pandemic by training leaders
In response to the COVID-19 pandemic and the prospect of others, public health and medical groups are developing training initiatives to increase the numbers of infectious disease and public health specialists across the country.
https://immattersacp.org/archives/2023/03/prepare-for-next-pandemic-by-training-leaders.htm
1 Mar 2023
Latest research looks at prolonged symptoms, drug treatments in COVID-19
Two studies found symptoms to be common months to a year after COVID-19 infection, while other research found benefits from interleukin-6 inhibitors but no significant effects of ivermectin, remdesivir, and hydroxychloroquine.
https://immattersacp.org/weekly/archives/2021/07/13/1.htm
13 Jul 2021
New reports on early symptoms, cardiac complications of COVID-19
Loss of smell and taste have been suggested as possible early symptoms of COVID-19, and cardiac complications appear to be a significant issue among infected patients with or without baseline cardiovascular disease.
https://immattersacp.org/weekly/archives/2020/03/31/2.htm
31 Mar 2020
CDC issues interim guidance on evaluation, treatment of suspected vaping injuries
The evaluation of patients with suspected e-cigarette, or vaping, product use-associated lung injury (EVALI) should include pulse oximetry, chest X-ray, and, in some cases, chest CT, the CDC advised.
https://immattersacp.org/weekly/archives/2019/10/22/2.htm
22 Oct 2019
ATS/IDSA release clinical practice guideline on diagnosing, treating CAP
The new American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA) guideline updates the 2007 community-acquired pneumonia (CAP) guideline, and changes include a different perspective on macrolides.
https://immattersacp.org/weekly/archives/2019/10/08/4.htm
8 Oct 2019
Working together to stop superbugs
The battle against antimicrobial resistance requires a broad line of attack, prompting the CDC to fund projects to expand regional efforts against multidrug-resistant organisms.
https://immattersacp.org/archives/2020/02/working-together-to-stop-superbugs.htm
1 Feb 2020
ACP, Annals of Internal Medicine host ‘Monkeypox: Challenging Clinical Questions’
The virtual forum featured a panel of physicians providing answers to commonly asked questions about the human monkeypox virus and is available for replay online.
https://immattersacp.org/weekly/archives/2022/10/18/5.htm
18 Oct 2022
IDSA updates treatment guidelines, while studies identify symptoms in specific age groups
The Infectious Diseases Society of America (IDSA) changed its recommendations on steroids, remdesivir, and other therapies. New research from Europe quantified COVID-19 symptoms in older adults as well as neurological complications.
https://immattersacp.org/weekly/archives/2020/06/30/1.htm
30 Jun 2020
New guidelines on COVID-19 antibody testing, flu vaccination and trial data on remdesivir
Infectious diseases experts offered guidance on the use of antibody tests in practice, a remdesivir trial showed disappointing results, the CDC recommended flu vaccination for people six months and up, and a study reported post-ICU outcomes of patients with COVID-19.
https://immattersacp.org/weekly/archives/2020/08/25/1.htm
25 Aug 2020